A Novel Non-Psychoactive Fatty Acid from a Marine Snail, Conus inscriptus, Signals Cannabinoid Receptor 1 (CB1) to

Christina Sathyanathan Vijayaraghavan1, Lakshmi Sundaram Raman2, Shanmugapriya Surenderan3

  • 1Department of Biotechnology, Faculty of Biomedical Sciences and Technology, SRI Ramachandra Institute of Higher Education and Research (SRIHER), Deemed to be University (DU), Porur, Chennai 600116, Tamil Nadu, India.

PubMed

Insights

A novel marine compound, C2, acts as a potent CB1 agonist, inducing apoptosis in ovarian cancer cells. This non-toxic compound shows no psychotropic effects in zebrafish, suggesting potential therapeutic applications.

Area of Science:

  • Pharmacology
  • Marine Biotechnology
  • Cancer Research

Background:

  • The cannabinoid type I (CB1) receptor plays a dual role in cell fate, influencing both survival and apoptosis.
  • Elevated CB1 receptor expression in cancers can lead to ceramide accumulation, supporting rapid tumor growth.
  • Paradoxically, sustained CB1 activation can trigger a secondary ceramide peak, inducing cancer cell death.

Purpose of the Study:

  • To investigate the effects of a novel marine compound (C2) on ovarian cancer cells.
  • To determine if C2 acts as a CB1 agonist and induces apoptosis.
  • To assess the safety and potential psychotropic effects of C2.

Main Methods:

  • Ovarian cancer cells (PA1) were treated with compound C2, isolated from *Conus inscriptus*.
  • CB1 receptor expression and intracellular ceramide levels (C:16, C:18) were measured.
  • Genotoxicity was assessed using micronuclei formation in Chinese hamster ovarian (CHO) cells.
  • Neurobehavioral changes were evaluated in zebrafish models.

Main Results:

  • Compound C2, a bis(palmitoleic acid) ester of glycerol, increased CB1 receptor expression threefold in PA1 cells.
  • C2 induced two acute ceramide pools, leading to G0/G1 arrest and apoptosis.
  • Intracellular ceramides C:16 and C:18 increased 7-fold and 10-fold, respectively, confirming C2 as a potent CB1 agonist.
  • C2 was not genotoxic in CHO cells and showed no observable neurobehavioral changes in zebrafish.

Conclusions:

  • The marine compound C2 effectively triggers the CB1 pathway, inducing apoptosis in ovarian cancer cells.
  • C2 demonstrates a dual ceramide-inducing mechanism, leading to cancer cell death.
  • C2 is non-toxic, non-genotoxic, and lacks psychotropic effects, indicating its safety for potential therapeutic use.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
237